COMPARISON OF CLEARANCE AND METABOLISM OF INFUSED CHOLECYSTOKININ-8 AND CHOLECYSTOKININ-58 IN DOGS

被引:39
|
作者
HOFFMANN, P
EBERLEIN, GA
REEVE, JR
BUNTE, RH
GRANDT, D
GOEBELL, H
EYSSELEIN, VE
机构
[1] UNIV CALIF LOS ANGELES, HARBOR MED CTR, DIV GASTROENTEROL, 1000 W CARSON ST, TORRANCE, CA 90509 USA
[2] CALIF BIOTECHNOL INST, MT VIEW, CA USA
[3] UNIV CALIF LOS ANGELES, CTR ULCER RES & EDUC, CTR DIGEST DIS, LOS ANGELES, CA USA
[4] UNIV ESSEN GESAMTHSCH, DIV GASTROENTEROL, W-4300 ESSEN 1, GERMANY
[5] VET ADM WADSWORTH HOSP, LOS ANGELES, CA USA
关键词
D O I
10.1016/0016-5085(93)91070-X
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Cholecystokinin (CCK) 58 is the predominant molecular form of CCK in canine and human intestine and circulating blood. There is no report on the metabolism and clearance rate of CCK-58. The aim of this study was to compare the in vivo half-life and metabolism of CCK-58 with that of synthetic CCK-8. Methods: CCK-58 was purified from canine intestine by consecutive high-performance liquid chromatographic (HPLC) and fast protein liquid chromatographic steps. The peptides were given to 12 dogs as an intravenous (IV) bolus injection to determine the half-life of circulating CCK. Six dogs were given CCK-58 or CCK-8 as a constant IV infusion to determine plasma clearance rates and stability in circulating blood. Circulating molecular forms of CCK were determined by radioimmunoassay after extraction of CCK from plasma and characterization by HPLC. Results: The half-life of CCK-58 was 4.4 ± 0.6 minutes compared with 1.3 ± 0.1 minutes for CCK-8. Less than 5% of CCK-58 could be detected as smaller forms during constant IV infusion. Conclusions: The longer half-life of CCK-58 compared with CCK-8 and the minimal conversion into smaller forms during constant IV infusion are consistent with the finding that CCK-58 is not only the major stored form but also the circulating form of CCK after endogenous stimulation in dogs. © 1993.
引用
收藏
页码:1732 / 1736
页数:5
相关论文
共 50 条
  • [31] THE EFFECTS OF CHOLECYSTOKININ-8 IN THE NUCLEUS TRACTUS SOLITARIUS
    DENAVITSAUBIE, M
    HURLE, MA
    MORINSURUN, MP
    FOUTZ, AS
    CHAMPAGNAT, J
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) : 375 - 384
  • [32] Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy
    Pellegrini, M
    Mierke, DF
    BIOCHEMISTRY, 1999, 38 (45) : 14775 - 14783
  • [33] ACCELERATED BREAKDOWN OF CHOLECYSTOKININ-58 IN THE BLOOD OF PATIENTS WITH ACUTE-PANCREATITIS
    EBERLEIN, GA
    EYSSELEIN, VE
    HESSE, WH
    SPRINGER, CJ
    CALAM, J
    GOEBELL, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1987, 25 (08): : 447 - 447
  • [34] PURIFICATION OF BOVINE CHOLECYSTOKININ-58 AND SEQUENCING OF ITS N-TERMINUS
    ENG, J
    LI, HR
    YALOW, RS
    REGULATORY PEPTIDES, 1990, 30 (01) : 15 - 19
  • [35] CHOLECYSTOKININ-58 (CCK-58) IS AN IMPORTANT CIRCULATING FORM IN HUMAN-BLOOD
    EBERLEIN, GA
    EYSSELEIN, VE
    HESSE, W
    ZUMSCHILDEEYCHENIE, J
    GOEBELL, H
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1986, 24 (09): : 487 - 487
  • [36] CHOLECYSTOKININ METABOLISM IN MAN AND DOGS
    THOMPSON, JC
    FENDER, HR
    RAMUS, NI
    VILLAR, HV
    RAYFORD, PL
    ANNALS OF SURGERY, 1975, 182 (04) : 496 - 504
  • [37] DISTINCT PROPERTIES OF CHOLECYSTOKININ-8 AND MIXED DOPAMINE-CHOLECYSTOKININ-8 NEURONS INNERVATING THE NUCLEUS ACCUMBENS
    STUDLER, JM
    REIBAUD, M
    TRAMU, G
    BLANC, G
    GLOWINSKI, J
    TASSIN, JP
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1985, 448 (JUL) : 306 - 314
  • [38] CHOLECYSTOKININ-8 INDUCES EDEMATOUS PANCREATITIS IN DOGS ASSOCIATED WITH SHORT BURST OF TRYPSINOGEN ACTIVATION
    SIMPSON, KW
    BEECHEYNEWMAN, N
    LAMB, CR
    SMYTH, JBA
    HUGHES, G
    COOMBE, K
    SUMAR, N
    HERMONTAYLOR, J
    DIGESTIVE DISEASES AND SCIENCES, 1995, 40 (10) : 2152 - 2161
  • [39] Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes
    Ahrén, B
    Holst, JJ
    Efendic, S
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (03): : 1043 - 1048
  • [40] Cholecystokinin-8 increases the satiety ratio in diabetic rats more than cholecystokinin-33
    Larsen, Christina J.
    Washington, Martha C.
    Sayegh, Ayman I.
    PHYSIOLOGY & BEHAVIOR, 2010, 101 (05) : 649 - 652